Procter & Gamble CO

The Procter & Gamble Company announced its fiscal year 2026 results, showing modest organic sales growth and core EPS in line with expectations, while providing guidance for fiscal year 2027.

The Procter & Gamble Company announces leadership changes with Shailesh Jejurikar appointed Chairman and Jon Moeller retiring.

The Procter & Gamble Company announced its fourth quarter and fiscal year 2026 results, reporting modest sales growth and earnings per share increases, while outlining expectations for continued progress in fiscal year 2027.

The Procter & Gamble Company announced its Board of Directors has declared a quarterly dividend of $1.0885 per share on its Common Stock and preferred stock, payable on or after August 17, 2026.

The Procter & Gamble Company announced its third quarter fiscal year 2026 results, showing sequential improvement in organic sales and core earnings per share.

The Procter & Gamble Company announced its fiscal year 2026 third quarter results, reporting a 7% increase in net sales to $21.2 billion and a 6% rise in diluted EPS to $1.63.

Procter & Gamble reports a 7% increase in quarterly net sales to $21.2 billion, driven by volume growth and pricing, despite ongoing restructuring costs.

Procter & Gamble reports a 1% net sales increase to $22.2 billion for Q2 FY26, with diluted EPS down 5% due to significant restructuring charges.

Procter & Gamble reported a 20% increase in net earnings to $4.8 billion for the first quarter, alongside a new $1.5-$2.0 billion restructuring plan and a $5 billion share repurchase program.

Procter & Gamble's Q3 2025 results reveal a slight dip in net sales offset by earnings growth driven by prior-year impairment charges, while the company navigates currency fluctuations and restructuring efforts.

Procter & Gamble's second quarter results show a mix of growth and challenges, with a 2% increase in net sales but a significant impact from restructuring and currency fluctuations.

Procter & Gamble's first quarter results show a slight decrease in net sales and a significant drop in net earnings due to restructuring charges, despite some positive growth in specific segments.

The Procter & Gamble Company announced its fiscal year 2026 results, showcasing a 3% increase in net sales to $87.0 billion and a 2% rise in diluted EPS to $6.62.

Procter & Gamble reported increased net earnings and diluted EPS for fiscal year 2025, driven by reduced selling, general, and administrative costs and the absence of a prior-year impairment charge, despite ongoing restructuring efforts.

Procter & Gamble's 2024 annual report highlights a 2% increase in net sales, driven by pricing and organic growth, alongside a 12% increase in core earnings per share, while also addressing macroeconomic headwinds and strategic restructuring.

Procter & Gamble Director Robert Portman acquired 5,155.46 shares of common stock through a Restricted Stock Unit award.

Procter & Gamble Director Ashley McEvoy acquired 202 shares of common stock through a grant of Restricted Stock Units.

Christine M. McCarthy, a Director at Procter & Gamble, acquired 253 shares of common stock on June 9, 2026.

Christopher J. Kempczinski, a Director at Procter & Gamble, acquired 258 shares of common stock on June 9, 2026, as part of a restricted stock unit award.

Procter & Gamble Director Joseph Jimenez acquired 320 shares of common stock through restricted stock units.

Procter & Gamble Director Craig Arnold acquired 202 shares of common stock on June 9, 2026, as part of a restricted stock unit award.

Procter & Gamble announces its 2025 Annual Meeting of Shareholders, detailing proposals including director elections, executive compensation, and a new stock plan.

Procter & Gamble details leadership changes, including a new CEO, proposes a new stock and incentive plan, and outlines shareholder voting matters for its upcoming annual meeting.

Procter & Gamble's annual shareholder meeting will be held virtually on October 8, 2024, with proposals including the election of directors, ratification of the accounting firm, executive compensation, and a shareholder proposal on pay gap reporting.

Procter & Gamble's proxy statement details the election of directors, executive compensation, and shareholder proposals for the upcoming annual meeting.

Vanguard Capital Management disclosed a beneficial ownership of 7.52% of Procter & Gamble's common stock as of March 31, 2026.

The Vanguard Group, Inc. filed an amended Schedule 13G, reporting 0% beneficial ownership of Procter & Gamble Co/The common stock following an internal realignment.

The Vanguard Group reported an increased beneficial ownership of 10.04% in Procter & Gamble Co/The common stock as of August 29, 2025.